Tom Oldfield | GenomeWeb

Tom Oldfield

Jan 29, 2015

Dotmatics has hired Tom Oldfield to be a principal software architect on its solutions development team. In the position, he'll be involved in the continuous expansion of Dotmatics' informatics solutions portfolio. 

Oldfield joins the company from the European Bioinformatics Institute (EMBL-EBI) where he was the head of databases and services for the Protein Databank in Europe. He also worked preciously for Accelrys, now Biovia, a Dassault Systèmes company, where he was responsible for developing software solutions for crystallography, sequence/structure alignment for proteins, and sequence alignment/information theory for genomic data.

More Like This

Mar 01, 2017

Dion Weisler

Thermo Fisher Scientific has appointed Dion Weisler to its board of directors. Weisler's appointment brings the total number of board members to 12. Currently, he serves as president and CEO of HP, and also serves on the company's board of directors. He previously served as executive VP of Hewlett-Packard's Printing and Personal Systems Business. Before joining HP, he served as VP and chief operating officer of product and mobile internet digital home groups at Lenovo.

Mar 01, 2017

Dirk van den Boom

CombiMatrix has appointed Dirk van den Boom to its board of directors. Dirk most recently served as president, CEO, and director of Sequenom, prior to its acquisition by LabCorp in September 2016. During his 18 year tenure at Sequenom, he held positions of increasing responsibility including chief scientific and strategy officer, executive VP of research and development, chief technology officer, and senior VP of research and development.

Mar 01, 2017

Hannes Smarason, John Long, Alex Fowkes

WuXi AppTec group subsidiary, WuXi NextCode, has appointed Hannes Smarason as CEO, John Long as CFO, and Alex Fowkes as chief operating officer. Smarason has been serving as COO for WuXi NextCode for the past two years. He co-founded NextCode Health in 2013, a spinout from deCode genetics, and he oversaw WuXi AppTec's aquisition of NextCode in 2015 and the company's merger with the WuXi Genome Center. Long has served as WuXi AppTec's senior vice president of finance since 2013. Prior to joining the company, he served in senior roles at Willis Group, Tyco International, and Lucent Technologies. Fowkes joined WuXi AppTec in 2012 where he initially led corporate development. He most recently served as senior vice president of commercial operations. Prior to WuXi, he served in a variety of roles for Pfizer in the US, UK, Australia, and China over 14 years.

Mar 01, 2017

Leroy Hood

BGI has appointed Leroy Hood to its scientific advisory board. In this role, Hood will provide professional advice to the company's genetic technology development efforts based on his experience and insights in the field. Currently, he is the president and co-founder of the Institute for Systems Biology, and senior vice president and chief scientific officer of Providence St. Joseph Health.

Feb 21, 2017

Raymond Stevens

Raymond Stevens has been appointed to Danaher's board of directors. Stevens currently serves as provost professor of biological sciences and chemistry and director of the Bridge Institute at the University of Southern California. Before that, he was a professor of molecular biology and chemistry at the Scripps Research Institute. 

Feb 20, 2017

John Thompson

Illumina has named John Thompson to its board of directors, effective May 3. Thompson is chairman of the board at Microsoft. He has also served as CEO at Symantec and Virtual Instruments, has held various roles over 28 years at IBM, and has served on the boards of Symantec, Northern Indiana Public Service Company, Fortune Brands, Seagate Technologies, and UPS. He is a member of the board of trustees for the Wetlands America Trust and was formerly a member of the national board of Teach for America. In addition, he has served on several government commissions, including the Financial Crisis Inquiry Commission, the National Infrastructure Advisory Council, and the Silicon Valley Blue Ribbon Task Force on Aviation Security and Technology. 

Feb 17, 2017

Igor Gitelman

Cancer Genetics has appointed Igor Gitelman the firm's principal accounting officer, replacing Victor Cross who had been promoted to that position in early January. The company said Cross left for family reasons. From late 2005 to late 2016 Gitelman was assistant vice president of finance and tax at BioReference Laboratories. 

Feb 17, 2017

Michael Terry

Biocept has appointed Michael Terry to the newly created position of senior vice president of commercial operations, where he will lead the company's commercial organization and oversee its business development initiatives. Prior to joining Biocept, Terry served as executive vice president of commercial operations and corporate development at liquid biopsy firm Trovagene. He has also served as executive vice president of Sequenom as CEO of neonatal diagnostics startup Ligand Dx, and has worked for Lumenis, GE Healthcare, and Aspect Medical Systems, among others.

Feb 17, 2017

Frederick Eibel

MolecularMD has appointed Frederick Eibel as senior vice president and chief marketing officer. Eibel joins MolecularMD from Wren Laboratories, where he served as senior vice president. Before his time at Wren, Eibel spent 23 years at Roche Diagnostics in various roles. He has also held leadership roles at Rain Dance Technologies, Sequenom, Life Technologies, and Gen Probe.

Feb 17, 2017

George Davis

Perthera has appointed George Davis to its board of directors. Davis currently serves as CEO of Gemstone Biotherapeutics. Previously, he served as president and vice chairman of Aether Systems. He has also served as CEO and director of Avatech Solutions.

Feb 16, 2017

Leeona Galligan

Almac Diagnostics has appointed Leeona Galligan as VP of UK Operations. She will be responsible for all UK-based operations, including commercial biomarker discovery, CLIA/FDA compliant analytical validation, downstream clinical testing, manufacturing and shipping of clinical specimens, and release of controls and reagents for registrational clinical trials. Galligan joined Almac in September 2009 as a senior scientist. She was appointed clinical testing laboratory manager in 2012 and was subsequently promoted to head of UK lab-based operations.

Feb 14, 2017

David Agus

David Agus has joined personalized oncology firm Tempus as Chairman of the firm's scientific advisory board. He is currently a Professor at the University of Southern California and head of its Ellison Institute for Transformative Medicine. Agus holds a medical degree from the University of Pennsylvania and completed a fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center.

Feb 10, 2017

Amy Sturm

Geisinger's Genomic Medicine Institute has appointed Amy Sturm as director of cardiovascular genomic counseling. Sturm also serves as a member of the ClinGen Cardiovascular Clinical Domain Working Group. She joins Geisinger from Ohio State University, where she served as associate professor in the Division of Human Genetics at OSU's Wexner Medical Center. She has served on the board of directors of the National Society of Genetic Counselors, and works extensively with the Familial Hypercholesterolemia Foundation and the Sudden Arrhythmia Death Syndromes Foundation.

Feb 09, 2017

Yaniv Erlich

MyHeritage has appointed Yaniv Erlich as chief science officer. He will lead the company's scientific development and strategy for its MyHeritage DNA service. Erlich comes to MyHeritage from Columbia University, where he served as assistant professor of computer science and computational biology. He has also served as a core member of the New York Genome Center, the principal investigator and Whitehead Fellow at MIT's Whitehead Institute, founder of DNA.LAND, and the principal investigator of the Erlich DNA lab.

Feb 09, 2017

Bradford Crutchfield

10x Genomics has appointed Bradford Crutchfield to the position of chief commercial officer, replacing John Pouk, who had been serving as the company's interim CCO. Pouk will stay on as senior vice president of commercial operations. Crutchfield previously served as senior vice president of Qiagen's life sciences business. He has also served as vice president and general manager of Illumina's Europe, Middle East, and Africa operations, as director of NanoString Technologies, and in various roles at Bio-Rad Laboratories. 

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.